NYSE:BDX

Becton, Dickinson and Stock Forecast, Price & News

$257.85
+8.03 (+3.21 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$250.77
Now: $257.85
$258.95
50-Day Range
$237.89
MA: $243.13
$250.70
52-Week Range
$219.50
Now: $257.85
$284.97
Volume2.07 million shs
Average Volume1.31 million shs
Market Capitalization$74.92 billion
P/E Ratio94.45
Dividend Yield1.33%
Beta0.79
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Becton, Dickinson and logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07588710
Phone201-847-6800
Employees70,000
Year Founded1897

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.12 billion
Cash Flow$17.40 per share
Book Value$81.98 per share

Profitability

Net Income$874 million

Miscellaneous

Market Cap$74.92 billion
Next Earnings Date5/6/2021 (Confirmed)
OptionableOptionable

Headlines

Is Becton Dickinson (BDX) Stock A Buy or Sell?
March 16, 2021 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

1.96 out of 5 stars

Medical Sector

70th out of 2,021 stocks

Surgical & Medical Instruments Industry

9th out of 169 stocks

Analyst Opinion: 1.3Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
$257.85
+8.03 (+3.21 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Becton, Dickinson and (NYSE:BDX) Frequently Asked Questions

Is Becton, Dickinson and a buy right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and in the last twelve months. There are currently 6 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Becton, Dickinson and stock.
View analyst ratings for Becton, Dickinson and
or view top-rated stocks.

What stocks does MarketBeat like better than Becton, Dickinson and?

Wall Street analysts have given Becton, Dickinson and a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Becton, Dickinson and wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Becton, Dickinson and's next earnings date?

Becton, Dickinson and is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Becton, Dickinson and
.

How can I listen to Becton, Dickinson and's earnings call?

Becton, Dickinson and will be holding an earnings conference call on Thursday, May 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Becton, Dickinson and's earnings last quarter?

Becton, Dickinson and Company (NYSE:BDX) issued its earnings results on Wednesday, February, 3rd. The medical instruments supplier reported $4.55 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $3.14 by $1.41. The medical instruments supplier had revenue of $5.32 billion for the quarter, compared to analyst estimates of $4.87 billion. Becton, Dickinson and had a trailing twelve-month return on equity of 13.30% and a net margin of 5.11%. The business's quarterly revenue was up 25.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.65 EPS.
View Becton, Dickinson and's earnings history
.

How has Becton, Dickinson and's stock been impacted by COVID-19?

Becton, Dickinson and's stock was trading at $231.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BDX stock has increased by 11.2% and is now trading at $257.85.
View which stocks have been most impacted by COVID-19
.

How often does Becton, Dickinson and pay dividends? What is the dividend yield for Becton, Dickinson and?

Becton, Dickinson and announced a quarterly dividend on Monday, January 25th. Stockholders of record on Wednesday, March 10th will be paid a dividend of $0.83 per share on Wednesday, March 31st. This represents a $3.32 annualized dividend and a yield of 1.29%. The ex-dividend date of this dividend is Tuesday, March 9th.
View Becton, Dickinson and's dividend history
.

Is Becton, Dickinson and a good dividend stock?

Becton, Dickinson and pays an annual dividend of $3.32 per share and currently has a dividend yield of 1.33%. Becton, Dickinson and has been increasing its dividend for 50 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Becton, Dickinson and is 32.55%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Becton, Dickinson and will have a dividend payout ratio of 24.79% next year. This indicates that Becton, Dickinson and will be able to sustain or increase its dividend.
View Becton, Dickinson and's dividend history.

What guidance has Becton, Dickinson and issued on next quarter's earnings?

Becton, Dickinson and updated its FY21 earnings guidance on Thursday, February, 4th. The company provided earnings per share guidance of $12.75-12.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.68. The company issued revenue guidance of +12-14% (implying $19.17-19.51 billion), compared to the consensus revenue estimate of $19.33 billion.

What price target have analysts set for BDX?

13 equities research analysts have issued 1 year price targets for Becton, Dickinson and's shares. Their forecasts range from $265.00 to $300.00. On average, they anticipate Becton, Dickinson and's stock price to reach $281.55 in the next twelve months. This suggests a possible upside of 9.2% from the stock's current price.
View analysts' price targets for Becton, Dickinson and
or view top-rated stocks among Wall Street analysts.

Who are Becton, Dickinson and's key executives?

Becton, Dickinson and's management team includes the following people:
  • Mr. Vincent A. Forlenza, Exec. Chairman (Age 68, Pay $2.51M)
  • Mr. Thomas E. Polen Jr., Pres, CEO & Director (Age 48, Pay $2.11M) (LinkedIn Profile)
  • Mr. Christopher R. Reidy, Exec. VP, CFO & Chief Admin. Officer (Age 64, Pay $1.4M) (LinkedIn Profile)
  • Mr. Samrat S. Khichi, Exec. VP of Regulatory & Gov. Affairs and Gen. Counsel (Age 54, Pay $2.19M) (LinkedIn Profile)
  • Mr. Alberto Mas, Exec. VP & Pres of the Medical Segment (Age 60, Pay $1.15M) (LinkedIn Profile)
  • Mr. Thomas J. Spoerel, VP, Controller & Chief Accounting Officer (Age 43)
  • Dr. John A. DeFord, Exec. VP of R&D and CTO (Age 59) (LinkedIn Profile)
  • Jerry Flasz, Exec. VP of Global Services & Chief Information Officer (LinkedIn Profile)
  • Ms. Monique N. Dolecki, Sr. VP of Investor Relations
  • Michelle Quinn, Sr. VP and Chief Ethics & Compliance Officer

What is Tom Polen's approval rating as Becton, Dickinson and's CEO?

136 employees have rated Becton, Dickinson and CEO Tom Polen on Glassdoor.com. Tom Polen has an approval rating of 91% among Becton, Dickinson and's employees. This puts Tom Polen in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Becton, Dickinson and's key competitors?

What other stocks do shareholders of Becton, Dickinson and own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Becton, Dickinson and investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), AT&T (T), NVIDIA (NVDA), The Walt Disney (DIS), Abbott Laboratories (ABT), Intel (INTC), Verizon Communications (VZ), Cisco Systems (CSCO) and CVS Health (CVS).

What is Becton, Dickinson and's stock symbol?

Becton, Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

Who are Becton, Dickinson and's major shareholders?

Becton, Dickinson and's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.20%), Retirement Systems of Alabama (0.09%), Cacti Asset Management LLC (0.07%), Tandem Investment Advisors Inc. (0.06%), Saratoga Research & Investment Management (0.05%) and Gillespie Robinson & Grimm Inc. (0.05%). Company insiders that own Becton, Dickinson and stock include Alexandre Conroy, Betty D Larson, Catherine M Burzik, Charles R Bodner, Claire Fraser, James C Lim, Patrick Kaltenbach, Ribo Alberto Mas, Roland Goette, Samrat S Khichi, Simon D Campion, Thomas J Spoerel and Vincent A Forlenza.
View institutional ownership trends for Becton, Dickinson and
.

Which institutional investors are selling Becton, Dickinson and stock?

BDX stock was sold by a variety of institutional investors in the last quarter, including Loring Wolcott & Coolidge Fiduciary Advisors LLP MA, UNIVEST FINANCIAL Corp, Retirement Systems of Alabama, First National Bank of Mount Dora Trust Investment Services, Huntington National Bank, Global Trust Asset Management LLC, Pacer Advisors Inc., and First Hawaiian Bank. Company insiders that have sold Becton, Dickinson and company stock in the last year include Patrick Kaltenbach, and Roland Goette.
View insider buying and selling activity for Becton, Dickinson and
or view top insider-selling stocks.

Which institutional investors are buying Becton, Dickinson and stock?

BDX stock was bought by a variety of institutional investors in the last quarter, including Saratoga Research & Investment Management, Cardinal Capital Management Inc., Tandem Investment Advisors Inc., Gofen & Glossberg LLC IL, Pensionfund DSM Netherlands, DnB Asset Management AS, Pensionfund Sabic, and Everence Capital Management Inc..
View insider buying and selling activity for Becton, Dickinson and
or or view top insider-buying stocks.

How do I buy shares of Becton, Dickinson and?

Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Becton, Dickinson and's stock price today?

One share of BDX stock can currently be purchased for approximately $257.85.

How much money does Becton, Dickinson and make?

Becton, Dickinson and has a market capitalization of $74.92 billion and generates $17.12 billion in revenue each year. The medical instruments supplier earns $874 million in net income (profit) each year or $10.20 on an earnings per share basis.

How many employees does Becton, Dickinson and have?

Becton, Dickinson and employs 70,000 workers across the globe.

Does Becton, Dickinson and have any subsidiaries?

The following companies are subsidiares of Becton, Dickinson and: (Bard Istanbul Healthcare Limited Company), ARX SA, Accuri Cytometers, Accuri Cytometers Inc., Alpha Altitude Sdn Bhd, Alverix, Alverix (M) Sdn. Bhd., Alverix Inc., Atto Bioscience, BD Holding S. de R.L. de C.V., BD Infection Prevention BV, BD Kiestra BV, BD Kiestra Total Lab Automation, BD Rapid Diagnostic (Suzhou) Co. Ltd., BD San Luis Potosi S.A. de C.V., BD Switzerland Sarl, BD Ventures LLC, BD West Africa Limited, BDX INO LLC, Bard (Thailand) Limited, Bard ASDI Inc., Bard Access Systems Inc., Bard Acquisition Sub Inc., Bard Australia Pty. Limited, Bard Benelux N.V., Bard Brachytherapy Inc., Bard Brasil Indústria e Comércio de Produtos Para a Saúde Ltda., Bard Canada Inc., Bard Chile S.p.A., Bard Colombia S.A.S., Bard Czech Republic s.r.o., Bard Devices Inc., Bard Dublin ITC Limited, Bard EMEA Finance Center Sp.z o.o., Bard European Distribution Center N.V., Bard Finance B.V. & Co. KG., Bard Financial Services Ltd., Bard Finland OY, Bard France S.A.S., Bard Healthcare Inc., Bard Healthcare Science (Shanghai) Limited, Bard Hellas S.A., Bard Holding SAS, Bard Holdings Limited, Bard Holdings Netherlands B.V., Bard Hong Kong Limited, Bard India Healthcare Pvt. Ltd., Bard International Holdings B.V., Bard International Inc., Bard Korea Ltd., Bard Limited, Bard MRL Acquisition Corp., Bard Malaysia Healthcare Sdn. Bhd., Bard Medica SA, Bard Medical Devices (Beijing) Co. Ltd., Bard Medical R&D (Shanghai) Co. Ltd., Bard Medical SA (Proprietary) Limited, Bard Mexico Realty S. de R.L. de C.V., Bard Norden AB, Bard Norway AS, Bard Pacific Health Care Company Ltd., Bard Peripheral Vascular Inc., Bard Poland Sp. z.o.o., Bard Reynosa S.A. de C.V., Bard S.r.l., Bard Sdn. Bhd., Bard Shannon Limited, Bard Singapore Private Limited, Bard Sourcing Office Singapore Pte. Ltd., Bard Sweden AB, Bard UK Newco Limited, Bard de Espana S.A., Becton Dickinson (Gibraltar) Holdings Ltd., Becton Dickinson (Gibraltar) Limited, Becton Dickinson (Gibraltar) Management Limited, Becton Dickinson (Mauritius) Limited, Becton Dickinson (Pty) Ltd., Becton Dickinson (Thailand) Limited, Becton Dickinson A.G., Becton Dickinson A/S, Becton Dickinson Argentina S.R.L., Becton Dickinson Asia Holdings Ltd., Becton Dickinson Asia Limited, Becton Dickinson Austria GmbH, Becton Dickinson Austria Holdings GmbH, Becton Dickinson B.V., Becton Dickinson B.V. Saudi Limited Company, Becton Dickinson Benelux N.V., Becton Dickinson Biosciences Systems and Reagents Inc., Becton Dickinson Canada Inc., Becton Dickinson Caribe Ltd., Becton Dickinson Croatia d.o.o., Becton Dickinson Czechia s.r.o., Becton Dickinson Dispensing Belgium BVBA, Becton Dickinson Dispensing Denmark A/S, Becton Dickinson Dispensing France SAS, Becton Dickinson Dispensing Ireland Limited, Becton Dickinson Dispensing Norway, Becton Dickinson Dispensing Spain S.L.U., Becton Dickinson Dispensing UK Ltd., Becton Dickinson Distribution Center N.V., Becton Dickinson East Africa Ltd., Becton Dickinson Euro Finance Sarl, Becton Dickinson Europe Holdings S.A.S., Becton Dickinson France S.A.S., Becton Dickinson GSA Beteilgungs GmbH, Becton Dickinson Global Holdings I Inc., Becton Dickinson Global Holdings II LLC, Becton Dickinson Global Holdings IV LLC, Becton Dickinson Global Holdings V LLC, Becton Dickinson GmbH, Becton Dickinson Guatemala S.A., Becton Dickinson Hellas S.A., Becton Dickinson Holdings Limited, Becton Dickinson Holdings Pte Ltd., Becton Dickinson Hungary Kft., Becton Dickinson India Private Limited, Becton Dickinson Industrias Cirurgicas Ltda., Becton Dickinson Infusion Therapy AB, Becton Dickinson Infusion Therapy B.V., Becton Dickinson Infusion Therapy Holdings UK Limited, Becton Dickinson Infusion Therapy Systems Inc., Becton Dickinson Infusion Therapy Systems Inc. S.A. de C.V., Becton Dickinson Infusion Therapy UK, Becton Dickinson Insulin Syringe Ltd., Becton Dickinson International Holdings II Pte Ltd., Becton Dickinson International Holdings III Pte Ltd., Becton Dickinson International Holdings Pte Ltd., Becton Dickinson Ireland Holdings Limited, Becton Dickinson Israel Ltd., Becton Dickinson Italia S.p.A., Becton Dickinson Ithalat Ihracat Limited Sirketi, Becton Dickinson Korea Holding Inc., Becton Dickinson Korea Ltd., Becton Dickinson Ltd., Becton Dickinson Luxembourg Finance S.a.r.L., Becton Dickinson Luxembourg Global Holdings Sarl, Becton Dickinson Luxembourg Holdings II S.a.r.L, Becton Dickinson Luxembourg Holdings III S.a.r.L, Becton Dickinson Luxembourg Holdings S.a.r.L, Becton Dickinson Luxembourg S.a.r.L., Becton Dickinson Malaysia Inc., Becton Dickinson Management GmbH & Co. KG, Becton Dickinson Matrex Holdings Inc., Becton Dickinson Medical (S) Pte Ltd., Becton Dickinson Medical Devices (Shanghai) Co. Ltd., Becton Dickinson Medical Devices (Suzhou) Co. Ltd., Becton Dickinson Medical Products Pte. Ltd., Becton Dickinson Netherlands Global Holdings II C.V., Becton Dickinson Netherlands Holdings B.V., Becton Dickinson Netherlands Holdings II B.V., Becton Dickinson Norway AS, Becton Dickinson O.Y., Becton Dickinson Overseas Services Ltd., Becton Dickinson Pakistan (Pvt) Ltd., Becton Dickinson Penel Limited, Becton Dickinson Philippines Inc., Becton Dickinson Polska Sp.z.o.o., Becton Dickinson Portugal Unipessoal Lda., Becton Dickinson Pty. Ltd., Becton Dickinson Research Centre Ireland Limited, Becton Dickinson Rowa Germany GmbH, Becton Dickinson Rowa Italy Srl, Becton Dickinson S.A., Becton Dickinson Sample Collection GmbH, Becton Dickinson Sdn. Bhd., Becton Dickinson Slovakia s.r.o., Becton Dickinson Sweden AB, Becton Dickinson Sweden Holdings AB, Becton Dickinson Switzerland Global Holdings SarL, Becton Dickinson Technology Campus India, Becton Dickinson U.K. Limited, Becton Dickinson Venezuela C.A., Becton Dickinson Venture LLC, Becton Dickinson Verwaltungs GmbH, Becton Dickinson Vostok LLC, Becton Dickinson Worldwide Investments Sa.r.L., Becton Dickinson Zambia Limited, Becton Dickinson and Company Ltd., Becton Dickinson de Colombia Ltda., Becton Dickinson de Mexico S.A. de C.V., Becton Dickinson del Uruguay S.A., Benex Ltd., Biometric Imaging, Bridger Biomed Inc., C. R. Bard, C. R. Bard (Portugal)-Produtos e Artigos Medicos e Farmaceuticos, C. R. Bard GmbH, C. R. Bard Inc., C. R. Bard Netherlands Sales B.V., CME America LLC, CME Ltd., CME Medical (UK) Limited, CME UK (Holdings) Limited, CRISI Medical Systems, CRISI Medical Systems Inc., Caesarea Medical Electronics, Cardal II LLC, Cardial S.A.S., Care Fusion Development Private Limited, CareFusion, CareFusion (Barbados) SrL, CareFusion (Shanghai) Commercial and Trading Co. Limited, CareFusion 213 LLC, CareFusion 2200 Inc., CareFusion 2201 Inc., CareFusion 302 LLC, CareFusion 303 Inc., CareFusion Asia (HK) Limited, CareFusion Australia 316 Pty Limited, CareFusion BH 335 d.o.o. Cazin, CareFusion Corporation, CareFusion D.R. 203 Ltd., CareFusion Finland 320 Oy, CareFusion France 309 S.A.S., CareFusion Germany 318 GmbH, CareFusion Iberia 308 S.L., CareFusion Israel 330 Ltd., CareFusion Italy 312 S.p.A., CareFusion Malaysia 325 Sdn Bhd, CareFusion Manufacturing LLC, CareFusion Netherlands 328 B.V., CareFusion Netherlands 503 B.V., CareFusion Netherlands 504 B.V., CareFusion Netherlands Financing 283 C.V., CareFusion Resources LLC, CareFusion S.A. 319 (Proprietary) Limited, CareFusion Solutions LLC, CareFusion U.K. 244 Limited, CareFusion U.K. 305 Limited, CareFusion U.K. 306 Limited, Carmel Pharma AB, Carmel Pharma Inc, Cato Software Solutions, Cell Analysis Systems Inc, Cellular Research, Cellular Research Inc., Clearstream Technologies Group Limited, Clearstream Technologies Limited, Clontech Laboratories Inc, Corporativo BD de Mexico S. de R.L. de C.V., Cytopeia, DLD (Bermuda) Ltd., DVL Acquisition Sub Inc., Davol Inc., Davol International Limited, Davol Surgical Innovations S.A. de C.V., Difco Laboratories Incorporated, Dutch American Manufacturers (D.A.M.) B.V., Dymax Corporation, Embo Medical Limited, Enturican Inc., FJ International Inc., FlowCardia Inc., FlowCardia LLC, FlowJo LLC, Franklin Lakes Enterprises L.L.C., Gamer Lasertechnik GmbH, GenCell Biosystems, GenCell Biosystems Ltd., GeneOhm Sciences, GeneOhm Sciences Canada Inc., Gentest Corporation, Gesco International Inc., Gesco International LLC, HandyLab Inc, HandyLab Inc., IBD Holdings LLC, JoHome LLC, Kabushiki Kaisha Medicon (Medicon Inc.), Liberator Health and Education Services Inc., Liberator Health and Wellness Inc., Liberator Medical Holdings Inc., Liberator Medical Supply Inc., Limited Liability Company Bard Rus, Loma Vista Medical Inc., Loma Vista Medical LLC, Lutonix Inc., Med-Safe Systems Inc., MedChem Products Inc., Medafor Inc., Medegen LLC, Medivance Inc., NOW Medical Distribution Inc., NOW Medical Distribution LLC, Navarre Biomedical LLC, Navarre Biomedical Ltd., Neomend Inc., Nippon Becton Dickinson Company Ltd., Omega Biosystems Incorporated, P.R.C.(Isialys)Societe a responsabilitie limitee(Societe a associe unique), PT Becton Dickinson Indonesia, PharMingen, PreAnalytiX GmbH, ProSeed Inc., Procesos para Esterilizacion S.A. de C.V., Productos Bard de Mexico S.A. de C.V., Productos Para el Cuidado de la Salud S.A. de C.V., Puls Medical Devices AS LC, PureWick Corporation, Roberts Laboratories Inc., Rochester Medical Corporation, Rochester Medical Ltd., Saf-T-Med, Safety Syringes, Safety Syringes Inc., Sendal S.L.U., SenoRx Inc., SenoRx LLC, Shield Healthcare Centers Inc., Sirigen, Sirigen II Limited, Sirigen Inc., Sistemas Médicos ALARIS S.A. de C.V., Specialized Health Products Inc., Specialized Health Products International Inc., Specialized Health Products International LLC, Staged Diabetes Management LLC, Surgical Site Solutions Inc., TVA Medical, TVA Medical GmbH, TVA Medical Inc., Touchstone Medical Limited, Tri-County Medical & Ostomy Supplies Inc., TriPath Imaging, TriPath Imaging Inc., Vas-Cath Incorporated, Vascular Pathways Inc., Venetec International Inc., Venetec International LLC, Y-Med Inc., and Y-Med LLC.

When was Becton, Dickinson and founded?

Becton, Dickinson and was founded in 1897.

What is Becton, Dickinson and's official website?

The official website for Becton, Dickinson and is www.bd.com.

Where are Becton, Dickinson and's headquarters?

Becton, Dickinson and is headquartered at 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417.

How can I contact Becton, Dickinson and?

Becton, Dickinson and's mailing address is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The medical instruments supplier can be reached via phone at 201-847-6800.


This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.